Obesity is a chronic disease that has become one of the biggest health problems on
the last decades. The etiology of obesity is multifactorial, which makes the success
of treatment more difficult. Intragastric balloon (BIB) is a short term, reversible,
minimally invasive method for weight loss. Furthermore, it helps changing eating habits
and behavior. It promotes gastric distension, resulting in decreased intake of food,
potentially delays gastric emptying and enhances the feeling of satiety. The objective
of this study was to evaluate the effects of BIB in patients with type 2 diabetes
mellitus (T2DM) and overweight or with grade I obesity, by analyzing the weight loss,
body composition, glucose and lipid metabolism and production of enterohormones.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gastrointestinal EndoscopyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2019 Published by Elsevier Inc.
